Sep 2026· Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin· Vol 31· 0 citations· 39 references
Medicine
TL;DR
Patients with RSV infection had a disease course comparable to patients with influenza or COVID-19 and a higher mortality rate, especially with increasing age, highlighting the importance of RSV vaccination in older adults and those with comorbidities, alongside established vaccination strategies for seasonal influenza and COVID-19.
Abstract
Background
Severe acute respiratory infections (SARI) cause substantial disease burden in older adults and those with comorbidities.
Aim
To inform Belgian vaccination policies, we aimed to compare risk profiles and outcomes of influenza, COVID-19 and RSV infections and examine age-related differences.
Methods
Adults (≥ 18 years) hospitalised with SARI in nine Belgian sentinel hospitals during the 2023/24 and 2024/25 winter seasons were included. Patients with laboratory-confirmed RSV infection, influenza or COVID-19 were compared in terms of demographics, comorbidities, complications and outcomes. Adults 18–64 years were compared with those ≥ 65 years. Multivariate analyses were applied.
Results
Among 2,806 patients, 535 (19.1%) had RSV infection, 1,694 (60.4%) influenza and 577 (20.6%) COVID-19. Patients with influenza were significantly younger (mean age 68.9 years) and had significantly fewer comorbidities (89.7%) than patients with RSV (73.8 years; 95.8%) or COVID-19 (74.0 years; 93.6%). Patients with COVID-19 experienced significantly fewer complications (40.8%) than patients with RSV (48.9%) or influenza (45.2%). Patients with RSV had higher in-hospital mortality (11.9%) than patients with influenza (7.3%; p = 0.089) or COVID-19 (6.9%; p = 0.037). Across pathogens, younger adults had relatively more comorbidities after adjusting for differences in the general population. They had shorter hospital stays and lower mortality, but higher intensive care unit admission rates.
Conclusion
Patients with RSV infection had a disease course comparable to patients with influenza or COVID-19 and a higher mortality rate, especially with increasing age. These findings highlight the importance of RSV vaccination in older adults and those with comorbidities, alongside established vaccination strategies for seasonal influenza and COVID-19.
OBJECTIVES
Respiratory syncytial virus (RSV) is an increasingly recognized cause of serious respiratory illness in adults, yet data from middle-income countries remain scarce. This study aimed to compare clinical outcomes of RSV and influenza virus infections in hospitalized and outpatient adults in Türkiye.
METHODS...
Irem Akdemir, Hasan Selçuk Özger, Tugba Akkaya Hocagil et al.· International Journal of Inf...· 0 citations
Vaccination showed little or no association with ICU admission, but was associated with a one-quarter reduction in IHD among hospitalized older adults, reinforcing its benefits against fatal in-hospital outcomes.
Diogo F. P. Marques, Angela M. C. Rose, S. Monge et al.· Expert Review of Vaccines· 0 citations
Assessment of vaccine effectiveness demonstrated protection against influenza hospitalisation and short-term protection against hospitalisation with COVID-19 in older people.
Hannah J. Morgan, Dominic E. Dwyer, Mark Holmes et al.· Communicable diseases intell...· 0 citations
Individuals with SARDs, especially receiving highly immunosuppressive therapies, experienced elevated COVID-19 burden and severe outcome risks throughout the pandemic, warranting their prioritized consideration during future public health emergencies.
S. Carazo, I. Colmegna, S. Bernatsky et al.· medRxiv· 0 citations
Background:
The development of vaccines has played a significant role in managing the pandemic of COVID-19. The objective of this study was to investigate the impact of COVID-19 vaccination on mortality and intensive care unit (ICU) admissions.
Methods:
This retrospective, single-center cohort study included hospitaliz...
Julian Madrid· Chulalongkorn Medical Journa...· 0 citations